ArticleOncotarget2016

hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance.

Elena Lastraioli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.